Florida Medical Clinic Owner and Pharmacy Technician Sentenced to Prison in Clinical Trial Fraud Scheme
A federal judge has sentenced a medical clinic owner and a pharmacy technician to prison for their involvement in a clinical trial fraud scheme that included the falsification and fabrication of clinical trial data. Miguel Angel Montalvo Villa, 53, of Miami, was convicted by a jury on September 5 of one count of conspiracy to commit wire fraud and one count of wire fraud. Montalvo Villa also was convicted of making a false statement to a regulatory investigator with the U.S. Food and Drug Administration (FDA).
According to court documents and evidence presented at trial, Montalvo Villa was a co-owner, president, and CEO of AMB Research Center Inc. (AMB), a medical clinic located in Miami that conducted clinical trials of new drugs for pharmaceutical companies and sponsors. Portela Martinez was an employee who served as recruiter, site manager, data entry specialist, and pharmacist.
The evidence showed that Montalvo Villa and Portela Martinez used the names and personal information of individuals without their knowledge or consent and listed them as enrolled subjects in a clinical trial for a drug that was being developed to treat Clostridium difficile-associated diarrhea (CDAD), a moderate to severe form of diarrhea. The trial evidence further showed that the defendants enlisted and used the names of family members and friends who purportedly participated as eligible subjects in the CDAD clinical trial – but no subject fully participated in that clinical trial, as required by the protocol.
The trial evidence showed that Montalvo Villa and Portela Martinez falsified, at a minimum, hundreds of pages of documents and entered that information and data into the clinical trial’s electronic databases to make it appear as though the purported clinical trial subjects were fully participating in the clinical trial. The trial evidence also showed that as part of the conspiracy, Montalvo Villa submitted falsified and fraudulent invoices for AMB to receive payments for conducting the clinical trial that totaled $277,920.
“Accurate clinical trial data is critical to the evaluation of new drug treatments,” said Principal Deputy Assistant Attorney General Brian M. Boynton, head of the Justice Department’s Civil Division. “The Justice Department will continue to work closely with its agency and law enforcement partners to uncover and prosecute clinical trial fraud.”
U.S. District Judge K. Michael Moore sentenced Montalvo Villa to 71 months in prison and Portela Martinez to 46 months in prison on November 30.
Mandatory Facts:
- Defendant: Miguel Angel Montalvo Villa, 53, of Miami
- Criminal Charges: conspiracy to commit wire fraud, wire fraud, and making a false statement to a regulatory investigator
- City and State: Miami, Florida
- Exact Date: September 5, 2023 (conviction), November 30, 2023 (sentencing)
- Sentence: 71 months in prison for Montalvo Villa, 46 months in prison for Portela Martinez
- Dollar Amount: $277,920
Related Federal Cases
- Nazaret Chakrian, ID Theft and Wire Fraud, California 2023 · Idaho
- Orlando Pascual Jr., HIV Treatment Medicare Fraud, Miami FL, 2023 · Alabama
- Juan A. Tony Marrero, Medicare Fraud Scheme, Miami FL, 2023 · Texas
- Juan A. Tony Marrero, Medicare Fraud Scheme, Miami FL, 2024 · Alabama
- Michael R. Synychak, Illicit Vape Sales, Florida 2023 · New York
Key Facts
- State: Federal
- Category: White Collar Crime|Fraud & Financial Crimes
- Source: DOJ Press Release â†â€â€
ðŸâ€Â’ Get the grimiest stories delivered weekly. Subscribe free →
